Cross-reactive TCR with alloreactivity for immunodominant HIV-1 epitope Gag TL9 with enhanced control of viral infection
The paper identifies a dual-reactive TCR that recognizes HIV-1 epitope Gag TL9 presented by both HLA B*81:01 and B*42:01, showing enhanced control of viral infection through structural and functional analysis.
bioRxiv · Jun 6, 2021 · PreprintImmunology